IE892191L - 3-KETO HMG-CoA REDUCTASE INHIBITORS - Google Patents

3-KETO HMG-CoA REDUCTASE INHIBITORS

Info

Publication number
IE892191L
IE892191L IE892191A IE219189A IE892191L IE 892191 L IE892191 L IE 892191L IE 892191 A IE892191 A IE 892191A IE 219189 A IE219189 A IE 219189A IE 892191 L IE892191 L IE 892191L
Authority
IE
Ireland
Prior art keywords
hmg
coa reductase
reductase inhibitors
keto
img
Prior art date
Application number
IE892191A
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/363,792 external-priority patent/US4968693A/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IE892191L publication Critical patent/IE892191L/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)

Abstract

TITLE OF THE INVENTION 3-KETO HMG-CoA REDUCTASE INHIBITORS Compounds of formula (I) and (II): <IMG> <IMG> (I) (II) are HMG-CoA reductase inhibitors. [CA1328877C]
IE892191A 1989-06-09 1989-07-06 3-KETO HMG-CoA REDUCTASE INHIBITORS IE892191L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/363,792 US4968693A (en) 1988-03-02 1989-06-09 3-keto HMG-COA reductase inhibitors

Publications (1)

Publication Number Publication Date
IE892191L true IE892191L (en) 1990-12-09

Family

ID=23431752

Family Applications (1)

Application Number Title Priority Date Filing Date
IE892191A IE892191L (en) 1989-06-09 1989-07-06 3-KETO HMG-CoA REDUCTASE INHIBITORS

Country Status (14)

Country Link
JP (1) JPH0324033A (en)
CN (1) CN1047863A (en)
AU (1) AU618106B2 (en)
CA (1) CA1328877C (en)
DK (1) DK330389A (en)
FI (1) FI893272A (en)
HU (1) HUT54133A (en)
IE (1) IE892191L (en)
IL (1) IL90847A0 (en)
NO (1) NO892761L (en)
NZ (1) NZ229806A (en)
PT (1) PT91204B (en)
YU (1) YU144589A (en)
ZA (1) ZA895140B (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668699A (en) * 1985-08-05 1987-05-26 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
PT85109A (en) * 1986-06-23 1987-07-01 Merck & Co Inc Process for the preparation of hydroxy-tetrahydropyranone derivatives or corresponding ring opened dihydroxy acids which are hmg-coa reductase inhibitors
US5073568A (en) * 1988-11-14 1991-12-17 Hoffmann-La Roche Inc. Antipsoriatic agents

Also Published As

Publication number Publication date
PT91204B (en) 1995-03-31
NO892761D0 (en) 1989-07-04
FI893272A (en) 1990-12-10
YU144589A (en) 1990-12-31
FI893272A0 (en) 1989-07-05
DK330389A (en) 1990-12-10
AU3783889A (en) 1990-12-13
AU618106B2 (en) 1991-12-12
DK330389D0 (en) 1989-07-04
JPH0324033A (en) 1991-02-01
HUT54133A (en) 1991-01-28
ZA895140B (en) 1990-03-28
CN1047863A (en) 1990-12-19
IL90847A0 (en) 1990-02-09
PT91204A (en) 1991-02-08
NZ229806A (en) 1991-12-23
NO892761L (en) 1990-12-10
CA1328877C (en) 1994-04-26

Similar Documents

Publication Publication Date Title
AU3006992A (en) Stabilized Pharmeceutical Compositions of HMG-CoA Reductase Inhibitors
AU6084686A (en) Novel hmg-coa reductase inhibitors
EP0433842A3 (en) 1,2,3-triazole derivatives active as inhibitors of the enzyme hmg-coa reductase and pharmaceutical compositions containing them
AU6527090A (en) Substituted cyclohexene derivatives as hmg-coa reductase inhibitors
WO1999002514A3 (en) Epothilone derivatives
AU4677199A (en) Multibinding inhibitors of topoisomerase
NO882218D0 (en) PROCEDURE FOR THE PREPARATION OF PHOSPHORUS HMG-COA REDUCTASE INHIBITORS.
EP0251625A3 (en) Novel hmg-coa reductase inhibitors
CA2135751A1 (en) 4-Mercaptoacetylamino-[2] Benzazepinone(3) Derivatives, and Use as Enkephalinase Inhibitors
AU6916894A (en) Refrigerant compositions including an acyclic fluoroether
AU2058992A (en) HMG-COA reductase inhibitors
EP0403487A4 (en) Novel hmg-coa reductase inhibitors
NO882219L (en) PROCEDURE FOR THE PREPARATION OF PHOSPHORUS HMG-COA REDUCTASE INHIBITORS.
AU7761398A (en) Hmg-coa reductase inhibitor preparation process
HUP0100820A3 (en) Process for the obtaining of hmg-coa reductase inhibitors of high purity
AU3745799A (en) Assays for the detection of microtubule depolymerization inhibitors
AU4543699A (en) Multibinding inhibitors of hmg-coa reductase
AU2175088A (en) Novel hmg-coa reductase inhibitors
EP0323866A3 (en) Novel hmg-coa reductase inhibitors
AU1750497A (en) Compounds capable of inhibiting hiv-1 infection
AU645287B2 (en) Quinoline and pyridine anchors for HMG-CoA reductase inhibitors
AU2651197A (en) Processes for the preparation of pyrimidine compound
EP0415488A3 (en) 7-substituted hmg-coa reductase inhibitors
IE892191L (en) 3-KETO HMG-CoA REDUCTASE INHIBITORS
AU2545697A (en) Novel uses of phospholipase c inhibitors